• Francis L. Black


“The simplest of all infectious diseases is measles,” said Kenneth Maxcy 50 years ago.(110) That was before the virus had been isolated or any serological test had become available. The picture is more complicated than Maxcy knew. The virus can persist in humans, at least in defective form, and the distribution of the disease has been made more complex by an artificially determined pattern of vaccine distribution. However, the distinctive clinical response, the durability of immunity, and the absence of both nonhuman hosts and serologically cross-reactive viruses of humans continue to make measles the ideal basic model of infectious disease epidemiology. Essentially every unvaccinated person still contracts measles,(31,43) and most infections are clinically identifiable by an experienced layperson.


Measle Virus Canine Distemper Virus Measle Vaccine Subacute Sclerosing Panencephalitis Measle Case 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aaby, P., Malnutrition and overcrowding-exposure in severe measles infection: A review of community studies, Rev. Infect. Dis. 10: 478–491 (1988).PubMedCrossRefGoogle Scholar
  2. 2.
    Aaby, P, Andersen, M., And Knudsen, K., Excess mortality after early exposure to measles, Int. J. Epidemiol. 22: 156–162 (1993).PubMedCrossRefGoogle Scholar
  3. 3.
    Aaby, P., Bukh, J., Lisse, I. M., And Smits, A. J., Measles mortality, state of nutrition, and family structure: A community study in Guinea-Bissau, J. Infect. Dis. 147: 693–701 (1983).PubMedCrossRefGoogle Scholar
  4. 4.
    Aaby, P., Same, B., Simonden, E, Whittle, H., Seck, A. M. C., Knudsen, K., Bennett, J., Markowitz, L., And Rhodes, P, Child mortality after high-titre measles vaccines in Senegal: The complete data set, Lancet 338: 1518–1519 (1991).PubMedCrossRefGoogle Scholar
  5. 5.
    Abu Becr, M., A Discourse on the Smallpox and Measles (R. Mead, Trans.), J. Brindley, London, 1748.Google Scholar
  6. 6.
    Adams, J. M., And Imagawa, D. T., Measles antibodies inmultiple sclerosis, Proc. Soc. Exp. Biol. Med. 111: 562–566 (1962).PubMedCrossRefGoogle Scholar
  7. 7.
    Albrecht, P., Herrmann, K., And Burns, G. R., Role of virus strain in conventional and enhanced measles plaque neutralization test, J. Virol. Methods 3: 251–260 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    Anderson, R. M., And May, R. M., Infectious Diseases of Humans. Dynamics and Control, Oxford Science Publications, Oxford, 1991.Google Scholar
  9. 8a.
    Anonymous, Global measles eradication: target 2010?, Epi Newsletter 18 (4): 1–3 (1996).Google Scholar
  10. 8b.
    Anonymous, Record five years measles-free, Epi Newsletter 18 (6): 1–3 (1996).Google Scholar
  11. 9.
    Antel, J. P., Richman, D. P, Medof, M. E., And Arneson, B. G. W., Lymphocyte function and the role of regulator cells in multiple sclerosis, Neurology 28: 106–110 (1978).PubMedCrossRefGoogle Scholar
  12. 10.
    Arneborn, P, And Biberfeld, G., T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella, Infect. Immun. 39: 29–37 (1983).PubMedGoogle Scholar
  13. 10a.
    Atkinson, W. L., Hadler, S. C., Redd, S. B., And Orenstein, W. A., Measles Surveillance-United States, 1991, Morb. Mort. Week. Rpts. 41 (SS6): 1–12 (1992).Google Scholar
  14. 11.
    Baczko, K., Brinckmann, U., Pardowitz, I., Rima, P. K., And Ter Meulen, V., Nucleotide sequences of the genes encoding the matrix protein of two wild-type measles virus strains, J. Gen. Virol. 72: 2279–2282 (1991).PubMedCrossRefGoogle Scholar
  15. 12.
    Barrett, T., Subbarao, S. M., Belsham, G. J., And Mahy, B. M. J., The molecular biology of the morbilliviruses, in: The Paramyxoviruses (D. W. Kingsbury, ED.), pp. 83–102, Plenum Press, New York, 1991.Google Scholar
  16. 13.
    Bartlett, M. S., Deterministic and stochastic models for recurrent epidemics, Third Berkeley Symp. Math. Stat. Prob. 4: 81–109 (1956).Google Scholar
  17. 14.
    Bartlett, M. S., The critical community size for measles in the United States, J. R. Stat. Soc. Ser. A 123: 37–44 (1960).CrossRefGoogle Scholar
  18. 15.
    BaslÉ, M. E, Russell, W. C., Goswami, K. K. A., Rebel, A., Giraudon, P., Wild, E, And Filmon, R., Paramyxovirus antigens in osteoclasts from Paget’s bone tissue detected by monoclonal antibodies, J. Gen. Virol. 66: 2103–2110 (1985).PubMedCrossRefGoogle Scholar
  19. 16.
    Bech, V., Studies on the development of complement fixing antibodies in measles patients, J. Immunol. 103: 252–253 (1962).Google Scholar
  20. 17.
    Bech, V., Measles epidemics in Greenland, Arch. Ges. Virusforsh. 17: 53–56 (1965).CrossRefGoogle Scholar
  21. 18.
    Bellanti, J. A., Sanga, R. I., Klutinis, B., Brandt, B., And Artenstein, M. S., Antibody response in serum and nasal secretion in children immunized with inactivated and attenuated measles virus vaccines, N. Engl. J. Med. 280:628–633 (1969).Google Scholar
  22. 18a.
    Bellini, W. J., Rota, J. S., And Rota, P. A., Virology of measles virus, J. Infect. Dis. 170: S15 - S23 (1994).PubMedCrossRefGoogle Scholar
  23. 19.
    Benjamin, B., And Ward, S. M., Leukocyte response to measles, Am. J. Dis. Child. 44: 921–963 (1932).Google Scholar
  24. 20.
    Berg, R. B., And Rosenthal, M. S., Propagation of measles virus in suspensions of human and monkey leukocytes, Proc. Soc. Exp. Biol. Med. 106: 581–585 (1961).CrossRefGoogle Scholar
  25. 21.
    Bhatt, P. N., Brandt, C. D., Weiss, R. A., Fox, J. P., And Schaffer, M. E, Viral infections of monkeys in their natural habitat in southern India, Am. J. Trop. Med. Hyg. 15: 561–566 (1966).PubMedGoogle Scholar
  26. 22.
    Bianco, P., Silvestrini, G., Ballanti, P., And Bonucci, E., Paramyxovirus-like nuclear inclusions identical to those of Pagets disease of bone detected in giant cells of primary oxalosis, Virchows Arch. 421: 427–433 (1992).CrossRefGoogle Scholar
  27. 23.
    Van Binnendijk, R. S., Pofi FN, M. C. M., DE Vries, P, Voorma, H. O., Osterhaus, A. D. M. E., And Uytdehaag, F. G. C. M., Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones, J. Immunol. 142: 2847–2854 (1989).PubMedGoogle Scholar
  28. 24.
    Black, E L., Growth and stability of measles virus, Virology 7: 184–192 (1959).PubMedCrossRefGoogle Scholar
  29. 25.
    Black, F. L., Measles endemicity in insular populations: Critical community size and its evolutionary implication, Theor. Biol. 11: 207–211 (1965).CrossRefGoogle Scholar
  30. 26.
    Black, F. L., Measles and mumps, in: Manual of Clinical Laboratory Immunology, 4th ed. (N. R. Rose, E. C. Demacario, J. L. Fahey, H. Friedman, And G. M. Penn, Eds.), pp. 596–599, American Society for Microbiology, Washington, DC, 1992.Google Scholar
  31. 27.
    Black, F. L., Measles active and passive immunity in worldwide perspective, Prog. Med. Viral. 36: 1–33 (1989).Google Scholar
  32. 28.
    Black, F. L., An explanation of high death rates among New World peoples when in contact with Old World diseases, Perspect. Biol. Med. 37: 292–307 (1993).Google Scholar
  33. 29.
    Black, F. L., Berman, L. L., Libel, M., Reichelt, C. A., Pinhiero, E. P., Travassos DA Rosa, A., Figueira, F., And Siquiera-Campos, E., Inadequate immunity to measles in children vaccinated at an early age: Effect of revaccination, Bull. Who 62: 315–319 (1984).PubMedGoogle Scholar
  34. 30.
    Black, E L., And Davis, D. E. M., Measles and readiness for reading and learning. II. New Haven study, Am. J. Epidemiol. 88: 337–344 (1968).PubMedGoogle Scholar
  35. 31.
    Black, E L., And Rosen, L., Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure, J. Immunol. 88: 725–731 (1962).PubMedGoogle Scholar
  36. 32.
    Black, E L., And Sheridan, S. R., Blood leukocyte response to live measles vaccines, Am. J. Dis. Child. 113: 301–304 (1967).PubMedGoogle Scholar
  37. 32a.
    Blixenkrone-Moller, M., Sharma, B., Varsanyi, T. M., Hu, A., Norrby, E., And Kovamees, J., Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript, J. Gen. Viral. 73: 885–893 (1992).CrossRefGoogle Scholar
  38. 33.
    Block, A. B., Orenstein, W. A., Ewing, W. M., Spin, W. H., Mallison, G. E, Herrmann, K. L., And Hinman, A. R., Measles outbreak in a pediatric practice: Airborne transmission in an office setting, Pediatrics 75: 676–683 (1985).Google Scholar
  39. 34.
    Bolker, B. M., And Grenfell, B. T., Chaos and biological complexity in measles dynamics, Proc. R. Soc. London Ser. B. 251: 75–81 (1993)CrossRefGoogle Scholar
  40. 35.
    Brody, J. A., Sever, J. L., Edgar, A., And Mcnew, J., Measles antibody titer in multiple sclerosis patients and their siblings, Neurology 22: 492–499 (1972).PubMedCrossRefGoogle Scholar
  41. 36.
    Burrows, J., And Cruickshank, J. G., At what age should measles vaccine be given? Report of a small trial in Bulawayo, Cent. Afr. J. Med. 22: 45–47 (1976).Google Scholar
  42. 37.
    Caballero, B., And Rice, A., Low serum retinal is associated with increased severity of measles in New York City children, Nutr. Rev. 50: 291–292 (1992).PubMedCrossRefGoogle Scholar
  43. 37a.
    Celers, J., Problémes de santé publique posés par la rougeole dans les pays favorisés, Arch. Ges. Virusforsch. 16: 5–18 (1965).PubMedCrossRefGoogle Scholar
  44. 38.
    Centers For Disease Control, Measles-United States, 1992, Morbid. Mortal. Week. Rep. 42: 378–381 (1993).Google Scholar
  45. 39.
    Centers For Disease Control, Absence of reported measles-United States, November 1993, Morbid. Mortal. Week. Rep. 42: 925–926 (1993)Google Scholar
  46. 41.
    Centers For Diseases Control, Recommended childhood immunization schedule-United States, Morbid. Mortal. Week. Rep. 44:RR-5 (1995).Google Scholar
  47. 42.
    Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., And Orenstein, W. A., Measles antibody: Reevaluation of protective titers,. 1. Infect. Dis. 162: 1036–1042 (1990).CrossRefGoogle Scholar
  48. 43.
    Chen, S. L., And Lam, S. K., Optimum age for measles immunization in Malaysia, Med. J. Malaysia 40: 281–288 (1985).PubMedGoogle Scholar
  49. 44.
    Christensen, P. E., Henning, S., Bang, H. O., Andersen, V., Jordal, B., And Jensen, O., An epidemic of measles in southern Greenland, 1951: Measles in virgin soil. II. The epidemic proper, Acta Med. Scand. 144: 430–449 (1952).CrossRefGoogle Scholar
  50. 45.
    Christie, C. D., Hirsch, J. L., Rogall, B., Merrill, S., Ramlal, A. A., Karian, V., And Black, F. L., Durability of passive antibody in Jamaican children, Int. J. Epidemiol. 19:698–702 (1990).Google Scholar
  51. 46.
    Committee ON Infectious Diseases, American Academy OF Pediatrics, Measles: Reassessment of the current immunization policy, Pediatrics 84: 1110–1113 (1989).Google Scholar
  52. 47.
    Connor, E., Morrison, S., Lane, J., Oleske, J., Sonke, R. L., And Connor, J., Safety, tolerance, and pharmacodynamics of systemic ribavirin in children with human immunodeficiency virus infection, Antimicrob. Agents Chemother. 37: 532–539 (1993).PubMedCrossRefGoogle Scholar
  53. 48.
    Crowley, J. C., Dowling, P. C., Menonna, J., Silverman, J. I., Schubach, D., Cook, S. D., And Blumberg, B. M., Sequence variability and function of measles virus 3’ and 5’ ends and intracistronic regions, Virology 164: 498–506 (1988).PubMedCrossRefGoogle Scholar
  54. 49.
    Dean, G., And Kurtzke, J. F., On the risk of multiple sclerosis according to age at immigration to South Africa, Br. Med. J. 3: 725–729 (1971).PubMedCrossRefGoogle Scholar
  55. 50.
    Diaz, T., Nunez, J. C., Rullan, J. V., Markowitz, L. E., Barker, N. D., And Horan, J., Risk factors associated with severe measles in Puerto Rico, Pediatr. Infect. Dis. J. 11: 836–840 (1992).PubMedCrossRefGoogle Scholar
  56. 51.
    Dietz, K., Overall population patterns in the transmission cycle of infectious disease agents, in: Population Biology of Infectious Diseases (R. M. Anderson And R. M. May, Eds.), pp. 87–102, Springer-Verlag, New York, 1984.Google Scholar
  57. 52.
    Dietz, V. J., Nieberg, P., Gubler, D. J., And Gomez, I., Diagnosis of measles by clinical case definition in dengue-endemic areas-Implications for measles surveillance and control, Bull. Who 70: 745–750 (1992).PubMedGoogle Scholar
  58. 53.
    Rig, R. E., Marcil, A., Chopra, A., And Richardson, C. D., The human CD46 molecule is a receptor for measles virus (Edmonston strain), Cell 75: 295–305 (1993).PubMedCrossRefGoogle Scholar
  59. 54.
    Ekbom, A., Zack, M., Adami, H-O., And Heimick, C., Is there clustering of inflammatory bowel disease at birth? Am. J. Epidemiol. 134: 876–886 (1991).PubMedGoogle Scholar
  60. 55.
    Enders, J. F., And Peebles, T. C., Propagation in tissue cultures of cytopathogenic agents from patients with measles, Proc. Soc. Exp. Biol. Med. 86: 277–286 (1954).PubMedCrossRefGoogle Scholar
  61. 56.
    Fine, P. E. M., And Clarkson, J. A., Measles in England and Wales-I: An analysis of factors underlying seasonal patterns, Int. J. Epidemiol. 11: 5–14 (1982).PubMedCrossRefGoogle Scholar
  62. 57.
    Fireman, P., Friday, G., And Klimate, J., Effect of measles vaccine on immunological responsiveness, Pediatrics 43: 264272 (1969).Google Scholar
  63. 58.
    Forthal, D. N., Blanding, J., Aarnaes, S., Peterson, E. M., DE LA Maza, L. M., And Tilles, J. G., Comparison of different methods and cell lines for isolating measles virus, J. Clin. Microbiol. 31: 695–697 (1993).PubMedGoogle Scholar
  64. 59.
    Foster, A., And Sommer, A., Childhood blindness from corneal ulceration in Africa: Causes, prevention and treatment, Bull. Who 64: 619–623 (1986).PubMedGoogle Scholar
  65. 60.
    Fox, J. P., Black, F. L., And Kogon, A., Measles and readiness for reading and learning, Am. J. Epidemiol. 88: 168–175 (1969).Google Scholar
  66. 61.
    FuLginiti, V. A., And Helfer, R. E., Atypical measles in adolescent siblings 16 years after killed virus vaccine, J.A.M.A. 244: 804–806 (1980).CrossRefGoogle Scholar
  67. Galinsky, M. S., Annotated nucleotide sequence and protein sequences for selected Paramyxoviridae, in: The Paramyxoviruses (D. W. Kingsbury, ED.), pp. 537–568, Plenum Press, New York, 1991.Google Scholar
  68. 63.
    Garenne, M., Sex differences in measles mortality: A world review, Harvard School of Public Health Working Paper Series No. 4 (1992).Google Scholar
  69. 64.
    Garenne, M., And Aaby, P., Pattern of exposure and measles mortality in Senegal, J. Infect. Dis. 161: 1088–1094 (1990).PubMedCrossRefGoogle Scholar
  70. 65.
    Garrene, M., Leroy, O., Beau, J-P., And Sene, I., Child mortality after high-titre measles vaccines: Prospective study in Senegal, Lancet 338: 903–906 (1991).CrossRefGoogle Scholar
  71. 65a.
    Gellen, B. G., And Katz, S. L., Putting a stop to a serial killer: Measles, J. Infect. Dis. 170: S1–2 (1994).CrossRefGoogle Scholar
  72. 66.
    Gibes, F. A., Gibes, E. I., Carpenter, P. R., And Spies, H. W., Electroencephalographic abnormality in “uncomplicated” childhood diseases, J.A.M.A. 171: 1030–1055 (1959).CrossRefGoogle Scholar
  73. 67.
    Gindler, J. S., Atkinson, W. A., Markowitz, L. E., And Hutchins, S. S., Epidemiology of measles in the United States in 1989 and 1990, Pediatr. Infect. Dis. J. 11: 841–846 (1992).PubMedCrossRefGoogle Scholar
  74. 68.
    Gindler, J. S., Cw’rs, F. T., Barnett-Antinori, M. E., Swint, E. B., Hadler, S. C., And Rullan, J. V., Successes and failures in vaccine delivery-Evaluation of the immunization delivery system in Puerto Rico, Pediatrics 91: 315–320 (1993).Google Scholar
  75. 69.
    Giraudon, P., Jacquier, M. F., And Wild, T. F., Antigenic analysis of African measles virus field isolates: Identification and localization of one conserved and two variable epitope sites on the NP protein, Virus Res. 18: 137–152 (1988).CrossRefGoogle Scholar
  76. 70.
    Gordon, M. T., Mee, A. P., Anderson, D. C., And Sharpe, P. T., Canine distemper transcripts sequenced from pagetic bone, Bone Miner. 19: 159–174 (1992).PubMedCrossRefGoogle Scholar
  77. 71.
    Gray, R. H., Char, G., Prabhakar, P., Bainbridge, R., And Johnson, B., Subacute sclerosing panencephalitis in Jamaica, West Indian Med. J. 25: 27–34 (1986).Google Scholar
  78. 72.
    Greenberg, M., Pelliteri, O., And Eisenstein, D. T., Measles encephalitis. I. Prophylactic effect of gamma globulin, J. Pediatr. 46: 652–647 (1955).Google Scholar
  79. 73.
    Gresser, I., And Katz, S. L., Isolation of measles virus from urine, N. Engl. J. Med. 263: 452–454 (1960).PubMedCrossRefGoogle Scholar
  80. 74.
    Griffiths, D. A., The effect of measles vaccination on the incidence of measles in a community, J. R. Stat. Soc. Ser. A. 136: 441–449 (1973).CrossRefGoogle Scholar
  81. 74a.
    Griffin, D. E., Ward, B. J., And Esolen, L. M., Pathogenesis of measles infection: A hypothesis for altered immune responses, J. Infect. Dis. 170: 524–31 (1994).CrossRefGoogle Scholar
  82. Gustafson, T. L., Leven, A. W., Brunell, P. A., Mueller, R. G., Buttery, C. M. G., And Sehulster, L. M., Measles outbreak in a fully immunized secondary school population, N. Engl. J. Med. 316:771–774 (1987)Google Scholar
  83. 76.
    Haase, A. T., Gantz, D., Eble, B., Walker, D., Stoweing, L., Ventura, P., Blum, H., Wietgrefe, S., Zupanic, M., Tourtellotte, W., Gibbs, C.J., JR., Norrby, E., And Rozenblatt, S., Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis, Proc. Natl. Acad. Sci. Usa 82: 3020–3024 (1985)Google Scholar
  84. 77.
    Haase, A. T., Gantz, D., Eble, B., Walker, D., Stowring, L., Ventura, P., Blum, H., Wietgrefe, S., Zupanic, M., Tourtellotte, W., Gibbs, C. J., JR., Norrby, E., And Rozenblatt, S., Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis, Proc. Natl. Acad. Sci. Usa 82: 3020–3024 (1985).PubMedCrossRefGoogle Scholar
  85. 78.
    Haase, A. T., Ventura, P., Gibbs, C. J., JR., And Tourtel-LoTte, W. W., Measles virus nucleotide sequences: Detection by hybridization in situ, Science 212: 672 (1981).Google Scholar
  86. 79.
    Haire, M., Fraser, E B., And Millar, J. H. D., Measles and other virus specific immunoglobulins in multiple sclerosis, Br. J. Med. 3: 612–615 (1973).CrossRefGoogle Scholar
  87. 80.
    Halsey, N. A., Modlin, J. E, Jabbour, J. T., Dubey, L., ED-Dins, D. L., And Ludwig, D. D., Risk factors in subacute sclerosing panencephalitis: A case-control study, Am. J. Epidemiol. 111: 415–424 (1980).PubMedGoogle Scholar
  88. 81.
    Halsey, N. A., The optimal age for administering measles vaccine in developing countries, in: Recent Advances in Immunization, Pan American Health Organization Scientific Publication 451, pp. 4–13, Pahd, Washington, DC, 1983.Google Scholar
  89. 82.
    Halsey, N. A., Modlin, J. F., And Jabbour, J. T., Subacute sclerosing panencephalitis (Sspe). An epidemiologic review, in: Persistent Viruses (J. G. Stevens, G. J. Todaro, And C. E. Fox, Eds.), pp. 101–113, Academic Press, New York, 1978.Google Scholar
  90. 83.
    Hamer, W. H., The Milroy lectures on epidemic disease in England-The evidence of variability and persistence of type, Lancet 1: 733–739 (1906).Google Scholar
  91. 84.
    Hankins, R. W., And Black, E L., Western blot analyses of measles virus antibody in normal persons and patients with multiple sclerosis, subacute sclerosing panencephalitis or atypical measles, J. Clin. Microbiol. 24: 324–329 (1986).PubMedGoogle Scholar
  92. 85.
    Hedrick, A. W., Monthly estimates of the child population susceptible to measles 1900–1931, Am. J. Hyg. 17: 613–636 (1933).Google Scholar
  93. 86.
    Helms, S., And Helms, R, Tuberculin sensitivity during measles, Acta Tuberc. Scand. 35: 166–171 (1956).Google Scholar
  94. 87.
    Hinman, A. R., Branling-Bennett, A. D., And Nieburg, P. I., The opportunity and obligation to eliminate measles from the United States, J.A.M.A. 242: 1157–1162 (1979).Google Scholar
  95. 88.
    Hinman, A. R., Orenstein, W. A., And Mortimer, E. A., When, where, and how do immunizations fail ? Ann. Epidemiol. 2: 805–812 (1992).PubMedCrossRefGoogle Scholar
  96. 89.
    Hirsch, A., Handbook of Geographical and Historical Pathology, Vol. 1, New Sydenham Society, London, 1883.Google Scholar
  97. 90.
    Holt, E. A., Moulton, L. H., Siberry, G. K., And Halsey, N. A., Differential mortality by measles vaccine titer and sex, J. Infect. Dis. 168: 1087–1096 (1993).PubMedCrossRefGoogle Scholar
  98. 91.
    Home, E, Medical Facts and Experiments, A, Millar, London, 1759.Google Scholar
  99. 90a.
    HU, A., Sheshberadaran, H., Norrby, E., AndVamees, J., Molecular characterization of epitopes on the measles virus hem-agglutinin protein, Virology 192: 351–354 (1993).PubMedCrossRefGoogle Scholar
  100. 91.
    Hussy, C. D., And Klein, A., A randomized controlled trial of vitamin A in children with severe measles, N. Engl. J. Med. 323: 160–164 (1990).CrossRefGoogle Scholar
  101. 92.
    Ikic, D. M., Edmonston-Zagreb strain of measles vaccine: Epidemiologic evaluation of Yugoslavia, Rev. Infect. Dis. 5: 558–563 (1983).PubMedCrossRefGoogle Scholar
  102. 93.
    John, T. J., And Steinhoff, M. C., Control of measles by annual pulse immunization, Am. J. Dis. Child. 138: 299–300 (1984).PubMedGoogle Scholar
  103. 94.
    DE Jong, J. G., And Winkler, K. O., Survival of measles virus in air, Nature 201: 1054–1055 (1964)PubMedCrossRefGoogle Scholar
  104. 95.
    Kapil, A., Broor, S., And Seth, P., Prevalence of Sspe: A serological study, Indian Pediatr. 29: 731–734 (1992).PubMedGoogle Scholar
  105. 96.
    Kaplan, L. J., Daum, R. S., Smaron, M., And Mccarthy, C. A., Severe measles in immunocompromised patients, J.A.M.A. 267: 1237–1241 (1992).PubMedCrossRefGoogle Scholar
  106. 97.
    Karelitz, S., Globulin extract of immune adult serum in prophylaxis of measles, Proc. Soc. Exp. Biol. Med. 31: 793–796 (1933).Google Scholar
  107. 98.
    Katz, S. L., Kempe, C. H., Black, E L., Lepow, M. L., Krug-Man, S. L., Haggerty, R. J., And Enders, J. F., Studies on an attenuated measles-virus vaccine. Viii. General summary and evaluation of the results of vaccination, N. Engl. J. Med. 273: 180–184 (1960).CrossRefGoogle Scholar
  108. 98a.
    Keeling, M. J., And Grenfeli., B. T., Disease extinction and community size: Modeling the persistence of measles, Science 275: 65–67 (1997).CrossRefGoogle Scholar
  109. 99.
    KoProwsKI, H., The role of hypergy in measles encephalitis, Am. J. Dis. Child. 103: 273–278 (1962).Google Scholar
  110. 100.
    Koster, F. T., Curlin, G. C., Aziz, K. M. A., And Haque, A., Synergistic impact of measles and diarrhea on nutrition and mortality in Bangladesh, Bull. Who 59: 901–908 (1981).PubMedGoogle Scholar
  111. 101.
    Krause, P. J., Cherry, J. D., Carney, J. M., Naiditch, H. J., And O’Connor, K., Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories, Am. J. Dis. Child. 134: 565–571 (1980).Google Scholar
  112. 102.
    Kress, S., Schleuderberg, A. E., Hornick, R. B., Morse, L. J., Cole, J. L., Slater, E. A., And Mccrumb, E. R., Studies with live attenuated measles-virus vaccine. II. Clinical and immunological response of children in an open community, Am. J. Dis. Child. 101: 701–707 (1961).PubMedGoogle Scholar
  113. 103.
    Krugman, S., Giles, J. P., Jacobs, A. M., And Friedman, H., Studies with a further attenuated measles-virus vaccine, Pediatrics 66: 471–488 (1965).CrossRefGoogle Scholar
  114. a. Landlaekni, Heilbrigdisskyslur (Public Health in Iceland) Rikisprentsmidjan Gutenberg, Reykjavik, 1941–1950.Google Scholar
  115. 104.
    Lennon, J. L., And Black, E. L., Maternally derived measles immunity in the era of vaccine-protected mothers, J. Pediatr. 108: 671–676 (1986).PubMedCrossRefGoogle Scholar
  116. 105.
    Leon, M. E., Ward, B., Kanashiro, R., Hernandez, H., Berry, S., Vaisberg, A., Escamilla, J., Campos, M., Bellomo, S., Azabache, V., And Halsey, N. A., Immunologic parameters 2 years after high-titer measles immunization in Peruvian children, J. Infect. Dis. 168: 1097–1104 (1993).PubMedCrossRefGoogle Scholar
  117. 106.
    Lievens, A. W., And Brunell, P. A., Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles, J. Clin. Microbiol. 24: 391–394 (1986).PubMedGoogle Scholar
  118. 107.
    Markowitz, L. E., Albrecht, P., Orenstein, W. A., Lett, S. M., Pugliese, T. J., And Farrell, D., Persistence of measles antibody after revaccination, J. Infect. Dis. 166: 205–208 (1992).PubMedCrossRefGoogle Scholar
  119. 108.
    Mashako, L. M. N., Kapongo, C. N., Nsibu, C. N., Malamba, M., Davachi, F., And Othepa, M. O., Evaluation de la couverture vaccinale des enfants moins de 2 ans a Kinshasa (Zaire), Arch. Fr. Pediatr. 49: 717–720 (1992).PubMedGoogle Scholar
  120. 109.
    Mata, L., The Children of Santa Maria Cauque, M.I.T. Press, Cambridge, MA, 1978.Google Scholar
  121. 110.
    Maxcy, K. F., Principles and methods of epidemiology, in: Viral and Rickettsial Infections of Man (T. M. Rivers, ED.), pp. 128–146, Lippincott, Philadelphia, 1948.Google Scholar
  122. 111.
    Mccormick, J. B., Halsey, N. A., And Rosenberg, R., Measles vaccine efficacy from secondary attack rates during a severe epidemic, J. Pediatr. 90: 13–16 (1977)PubMedCrossRefGoogle Scholar
  123. 112.
    Mcneill, W. H., Plagues and Peoples: A Natural History of Infectious Diseases, Doubleday, New York, 1976.Google Scholar
  124. 113.
    Ter Meulen, V., MÜLler, D., Kackell, Y., Katz, M., And Mayermann, R., Isolation of infectious measles virus in measles encephalitis, Lancet 2: 1172–1175 (1972).PubMedCrossRefGoogle Scholar
  125. 1.
    Miller, C. L., Current impact of measles in the United Kingdom, Rev. Infect. Dis. 5: 427–432 (1983).CrossRefGoogle Scholar
  126. 115.
    Miller, C, Farrington, C. P., And Harbert, K., The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970–1989, Int. J. Epidemiol. 21: 998–1006 (1992).PubMedCrossRefGoogle Scholar
  127. 116.
    Mills, B. G., And Singer, F. R., Nuclear inclusions in Paget’s disease of bone, Science 194: 201–202 (1976).PubMedCrossRefGoogle Scholar
  128. 117.
    Mitis, A., Holloway, A., Evans, A. E., And Enders, J. E, Attenuated measles vaccine in children with acute leukemia, Am. J. Dis. Child. 103: 413–418 (1962).Google Scholar
  129. 118.
    Morley, D., The severe measles of West Africa, Proc. R. Soc. Med. 57: 846–849 (1969).Google Scholar
  130. 119.
    Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., RossI, B., Rabourdin-Combe, C., And Gerlier, D., Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus, J. Virol. 67: 6025–6032 (1993).PubMedGoogle Scholar
  131. 120.
    Neel, J. V., Centerwall, W. R., Chagnon, N. A., And Casey, H. L., Notes on the effect of measles in a virgin-soil population of South American Indians, Am. J. Epidemiol. 91: 418–429 (1970).Google Scholar
  132. 121.
    Neumann, P. W., Weber, J. M., Jessamine, A. G., And O’Shaughnessy, M. V., Comparison of measles antihemolysis test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status, J. Clin. Microbiol. 22: 296–298 (1985).PubMedGoogle Scholar
  133. 122.
    Norrby, E., Viral antibodies in multiple sclerosis, Prog. Med. Virol. 24: 1–39 (1978).PubMedGoogle Scholar
  134. 123.
    Norrby, E., Paramyxoviridae: Measles virus, in: Laboratory Diagnosis of Infectious Diseases. Principles and Practice (E. H. Lennette, P. Halonen, And E. A. Murphy, Eds.), pp. 525–539, Springer-Verlag, New York, 1988.Google Scholar
  135. 124.
    Norrby, E., Enders-Ruckle, G., And Ter Meulen, V, Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus, J. Infect. Dis. 132: 262–269 (1975).PubMedCrossRefGoogle Scholar
  136. 125.
    Nutels, N., Medical problems of newly contacted Indian groups, Pan. Am. Health Org. Sci. Publ. 165: 68–76 (1964).Google Scholar
  137. 126.
    Okuno, Y., Ueda, S., Kurimura, T., Suzuki, N., Yamanishi, K., Baba, K., Takahashi, M., Konobe, T., Sasada, T., Onishi, K., And Takaku, K, Studies on further attenuated live measles vaccine. Vii. Development and evaluation of Cam-70 measles virus vaccine, Biken J. 14: 253–258 (1971).PubMedGoogle Scholar
  138. 127.
    Onorato, L M., Markowitz, L. E., And Oxtoby, M. T., Childhood immunization, vaccine preventable diseases, and infection with Hiv, Pediatr. Infect. Dis. J. 7: 588–595 (1988).PubMedGoogle Scholar
  139. 128.
    Palombo, P., Hoyt, L., Demasio, K., Oleske, J., And Connor, E., Population-based study of measles and measles immunization in human immunodeficiency virus-infected children, Pediatr. Infect. Dis. J. 11: 1008–1014 (1992).CrossRefGoogle Scholar
  140. 129.
    Pampiglione, G., Prodromal phase of measles: Some neurophysiological studies, Br. Med. J. 2: 1296–1300 (1964).PubMedCrossRefGoogle Scholar
  141. 130.
    Pan American Health Organization And The Ministries OF Health OF Brazil, Chile And Ecuador, Seroconversion rates and antibody titer induced by measles vaccine in Latin AmericanGoogle Scholar
  142. 131.
    Pannuti, C. S., Morass, J. C., Souza, V. A. U. E, Camargo, M. C. C., And Hidalgo, N. R. T., Vaccine effectiveness in Saô Paulo, Bull. Who 69: 557–560 (1991).PubMedGoogle Scholar
  143. 132.
    Panum, R. L., Observation Made during the Epidemic of Measles on the Faroe Islands in the Year 1846, American Publishing Association, New York, 1940.Google Scholar
  144. 133.
    Peart, A. E W., And Nagler, F. P., Measles in the Canadian Arctic, 1952, Can. J. Public Health 45: 146–157 (1954).PubMedGoogle Scholar
  145. 134.
    Rahmathullah, L., Underwood, B. A., Thulasiraj, R. D., Milton, R. C., Ramaswamy, K., Rahmathullah, R., And Babu, G., Reduced mortality among children in southern India receiving small weekly doses of Vitamin A, N. Engl. J. Med. 323: 929–935 (1990).PubMedCrossRefGoogle Scholar
  146. 135.
    Reddy, V., Bhaskaram, B. R, Raghuramula, N., Milton, R. C., Rao, V., Madhusudan, J., And Radha Krishna, K. V., Relationship between measles, malnutrition and blindness: A prospective study in Indian children, Am. J. Clin. Nutr. 44: 924–930 (1986).PubMedGoogle Scholar
  147. 136.
    Robertson, D. A. E, Zhang, S. L., Guy, E. C., And Wright, R., Persistent measles virus genome in autoimmune chronic active hepatitis, Lancet 2: 9–11 (1987).PubMedCrossRefGoogle Scholar
  148. 137.
    Rolleston, J. D., History of Acute Exanthemata, Heinemann, London, 1937.Google Scholar
  149. 138.
    Rota, J. S., Hummel, K. B., Rota, P. A., And Bellini, W. J., Genetic variability of the glycoprotein genes of current wild-type measles virus isolates, Virology 188: 135–142 (1992).PubMedCrossRefGoogle Scholar
  150. 139.
    Ruchdeschel, J. C., Graziano, K. D., And Mardiney, M. R., JR., Additional evidence that the cell-associated immune system is the primary host defense against measles, Cell. Immunol. 17: 11–18 (1975).CrossRefGoogle Scholar
  151. 140.
    Sarvas, H., Seppala, I., Kurikka, S., Siegberg, R., And Makela, O., Half-life of the maternal IgG1 allotype in infants, J. Clin. Immunol. 13: 145–151 (1993).PubMedCrossRefGoogle Scholar
  152. 141.
    Schaffner, W., Schleuderberg, A. E. S., And Byrne, E. B., Clinical epidemiology of sporadic measles in a highly immunized population, N. Engl. J. Med. 279: 783–789 (1968).PubMedCrossRefGoogle Scholar
  153. 142.
    Schleuderberg, A. E., Immune globulins in human viral infections, Nature 205: 1232–1233 (1965).CrossRefGoogle Scholar
  154. 143.
    Schultz, F., Die Epideiologie der Mazern, Gustaf Fischer, Jena, Germany, 1925.Google Scholar
  155. 144.
    Sencer, D., Dull, H. B., And Langmuir, A. D., Epidemiologic basis for eradication of measles in 1967, Public Health Rep. 82: 253–256 (1967).PubMedCrossRefGoogle Scholar
  156. 145.
    Shasby, D. M., Shope, T. C., Downs, H., Hermann, K. L., And PoLkowsKt, J., Epidemic measles in a highly vaccinated population, N. Engl. J. Med. 296: 585–589 (1977).PubMedCrossRefGoogle Scholar
  157. 146.
    Sheshberadaran, H., And Norrby, E., Characterization of epitopes of the measles virus hemagglutinin, Virology 152: 58–69 (1986).PubMedCrossRefGoogle Scholar
  158. 147.
    Sheshberadaran, H., Norrby, E., Mccullough, K. C., Carpenter, W. C., And Orvell, C., The antigenic relationship between measles, canine distemper and rinderpest studied with monoclonal antibodies, J. Gen. Virol. 67: 1381–1393 (1986).PubMedCrossRefGoogle Scholar
  159. 148.
    Siber, G. R., Werner, B. G., Halsey, N. A., Reid, R., Almeidohill, J., Garrett, S. C., Thompson, C., And Santosham, M., Interference of immune globulin with measles and rubella immunization, J. Pediatr. 122: 204–211 (1993).PubMedCrossRefGoogle Scholar
  160. 149.
    Smaron, M. E, Saron, E., Wood, L., Mccarthy, C., And Morello, J. A., Diagnosis of measles by fluorescent antibody and culture of nasopharyngeal secretions, J. Virol. Methods 33: 223–229 (1991).PubMedCrossRefGoogle Scholar
  161. 150.
    Smith, E R., Curran, A. S., Raciti, A., And Black, F. L., Reported measles in persons immunologically primed by-prior vaccination, J. Pediatr. 101: 391–393 (1982).PubMedCrossRefGoogle Scholar
  162. 151.
    Smorodintsev, A. A., Boichuk, L. M., Shikina, E. S., Bata-Nova, T. B., Bystryakova, L. V., And Peradze, T. V., Clinical and immunological response to live tissue culture vaccine against measles, Acta Virol. 4: 201–214 (1960).PubMedGoogle Scholar
  163. 152.
    Stover, C. K., DE LA Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. R, Young, J. E, Lee, M. H., Hatfull, G. F., Snapper, S. B., Barletta, R. G., Jacobs, W. R., JR., And Bloom, B. R., New use of Bcg for recombinant vaccines, Nature 351: 456–460 (1991).PubMedCrossRefGoogle Scholar
  164. 153.
    Suringa, D. W. R., Bank, L. J., Andackerman, A. B., Role of measles in skin lesions and Koplik spots, N. Engl. J. Med. 283: 1139–1142 (1970).PubMedCrossRefGoogle Scholar
  165. 154.
    Sydenham, T., The Works of Thomas Sydenham, Vol. 2, Sydenham Society, London, 1922.Google Scholar
  166. 155.
    Takahara, K., Hashimoto, H., Ri, T., Mom, T., And Yoshimura, M., Characterization of baculovirus-expressed hemagglutinin and fusion glycoproteins of the attenuated measles virus strain Aik-C, Virus Res. 26: 167–175 (1992).CrossRefGoogle Scholar
  167. 156.
    Tartarglia, J., Cox, W. I., Taylor, J., Pinkus, M., Riviere, M., Meignier, B., And Paoletti, E., Highly attenuated poxvirus vectors, Aids Res. Hum. Retroviruses 8: 1445–1447 (1992).Google Scholar
  168. 157.
    Taylor, J., Pincus, S., Tartaglia, J., Richardson, C., Alkhatib, G., Briedis, D., Appel, M., Norton, E., And Paoletti, E., Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge, J. Virol. 65: 4273–4274 (1991).Google Scholar
  169. 158.
    Taylor, M. J., Godfrey, E., Baczko, K., Ter Meulen, V., And Rima, B. K., Identification of several lineages of measles virus, J. Gen. Virol. 72: 83–88 (1992).CrossRefGoogle Scholar
  170. 159.
    Tulchinski, T. H., Ginsberg, G. M., Abed, Y., Angeles, M. T., Akukwe, C., And Bonn, J., Measles control in developing and developed countries-The case for a 2-dose policy, Bull. Who 71: 93–103 (1993).Google Scholar
  171. 159a.
    Varior-Krisi-Inan, G., Trescol-Biemont, M-C., Naniche, D., Rabourdin-Combe, C., And Gerlier, D., Glycosyl-phosphatidylinositol-anchored and transmembrane forms of CD46 display similar measles receptor binding properties: Virus binding, fusion and replication; down-regulation by hemagglutinin; and virus uptake and endocytosis for antigen presentation by major histocompatibility complex class II molecules, J. Virol. 68: 7891–7899 (1994).Google Scholar
  172. 160.
    Varsanyi, T. M., Morein, B., Love, A., And Norrby, E., Protection against lethal measles infection in mice by immune-stimulating complexes containing the hemagglutinin of fusion proteins, J. Virol. 61: 3896–3901 (1987).PubMedGoogle Scholar
  173. 161.
    Wakefield, A. J., Pittilo, R. M., Cosby, S. L., Stephenson, J. R., Dhillon, A. R, And Pounder, R. E., Evidence of persistent measles virus infection in Crohn’s disease, J. Med. Virol. 39: 345–353 (1993).PubMedCrossRefGoogle Scholar
  174. 162.
    Wechsler, S. L., Weiner, H. L., And Fields, B. N., Immune response in subacute sclerosing panencephalitis: Reduced antibody response to the matrix protein of measles virus, J. Immunol. 123: 884–889 (1979).PubMedGoogle Scholar
  175. 163.
    Whittle, H. C., Rowland, M. G. M., Mann, G. E, Lamb, W. H., And Lewis, R. A., Immunization of 4–6 month old Gambian infants with Edmonston-Zagreb measles vaccine, Lancet 2: 834–837 (1984).PubMedCrossRefGoogle Scholar
  176. 164.
    Wild, T. F., Bernard, A., Spehner, D., Villeval, D., And Drillien, R., Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens, Vaccine 11: 438–444 (1993).PubMedCrossRefGoogle Scholar
  177. 165.
    World Health Organization, Expanded program on immunization. Safety of high titer measles vaccine, Wkly. Epidemiol. Rec. 67: 357–361 (1992).Google Scholar
  178. 166.
    Zell, E, Low vaccination levels in U.S. preschool and school-aged children: Retrospective assessment of vaccination coverage, 1991–1992, J.A.M.A. 271: 833–839 (1994).CrossRefGoogle Scholar
  179. Barrett, T., Subbarao, S. M., Belsham, G. J., And Mahy, B. W. J., The molecular biology of the morbilliviruses, in: The Paramyxoviruses (D. W. Kingsbury, ED.), pp. 83–102, Academic Press, New York, 1991.Google Scholar
  180. Enders, J. E, Measles virus: Historical review, isolation and behavior in various systems, Am. J. Dis. Child. 103: 112–117 (1962).Google Scholar
  181. Halsey, N. A., Increased mortality after high titer measles vaccines: Too much of a good thing, Pediatr. Infect. Dis. J. 12: 462–465 (1993).PubMedCrossRefGoogle Scholar
  182. Markowrrz, L. E., And Orenstein, W. A., Measles vaccines, Pediatr. Clin. North Am. 37: 603–625 (1990).Google Scholar
  183. Norrby, E., Immunobiology of the paramyxoviruses, in: The Para- myxoviruses (D. W. Kingsbury, ED.), pp. 83–102, Academic Press, New York, 1991.Google Scholar
  184. Panum, P. L., Observation Made during the Epidemic of Measles on the Faroe Islands in the Year 1846, American Publishing Association, New York, 1940.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Francis L. Black
    • 1
  1. 1.Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations